Article
Death Receptor 6 as a Prognostic Marker in Low-grade Glioma.
Anticancer research - 1 Mar 2022
Stegmann Sarah K, Kuhl Saskia, Im Nam Gyu, Diem-Dinh Dang Thuy, Goertz Lukas, Goldbrunner Roland, Timmer Marco
Abstract excerpt
BACKGROUND/AIM: Low-grade gliomas (LGG) are heterogenous tumours, causing variable survivals in patients. Identifying molecular markers for a more accurate prognosis is, therefore, important. Since death receptor 6 (DR6) is up-regulated in gliomas and shows an aberrant signalling network, we tested its suitability as a prognostic marker. MATERIALS AND METHODS: DR6 was investigated in patient samples via PCR and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.